Biodesix Expands Bio-Rad Partnership for Droplet Digital PCR Assay Development
The agreement focuses on clinical validation of ESR1 mutation detection assay for advanced breast cancer testing using ddPCR technology.
Read MorePosted by CLP Edit Staff | Oct 24, 2025 | Breast |
The agreement focuses on clinical validation of ESR1 mutation detection assay for advanced breast cancer testing using ddPCR technology.
Read MorePosted by CLP Edit Staff | Oct 24, 2025 | Cancer |
PATHFINDER 2 study results indicate more than half of cancers detected by Galleri test were found in early stages, with three-quarters having no current screening options.
Read MorePosted by CLP Edit Staff | Oct 23, 2025 | Lung Cancer |
The permit enables the company to offer its PROphetNSCLC test to physicians and patients across New York State, completing nationwide availability.
Read MorePosted by CLP Edit Staff | Oct 23, 2025 | Cancer |
German laboratory brings tumor-informed MRD testing to European market through licensing agreement with Quest Diagnostics subsidiary.
Read MorePosted by CLP Edit Staff | Oct 10, 2025 | Molecular Diagnostic Analyzers |
The machine learning-powered platform analyzes gene expression data from biopsies to provide molecular scores for rejection probability and tissue injury.
Read More